Herantis Pharma Oyj (HRTIS) — Cash Flow Reinvestment Rate
Latest as of December 2013:
2299.45x
Herantis Pharma Oyj (HRTIS) has a Cash Flow Reinvestment Rate of 2299.45x as of December 2013, reinvesting €421.35K (capex €421.35K ) from operating cash flow of €183.24. Explore HRTIS capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
2299.45x
(Capex + Investments) / Operating CF
Total Reinvested
€421.35K
Capex + Investments
Operating Cash Flow
€183.24
EUR
Capital Expenditures
€421.35K
EUR
Annual Cash Flow Reinvestment Rate for Herantis Pharma Oyj (None–None)
Year-by-year capital reinvestment analysis for Herantis Pharma Oyj. For live market cap and broader valuation context, see market cap of Herantis Pharma Oyj.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow